Stauber Inc. and NextFerm Technologies have signed a sales and distribution agreement for NextFerm’s fermented astaxanthin ingredient Astaferm.
Stauber Inc. (Fullerton, CA) and NextFerm Technologies (Yokneam Illit, Israel) have signed a sales and distribution agreement for NextFerm’s fermented astaxanthin ingredient Astaferm.
“This announcement represents a significant stage in our long-term plan to take the leading position in the astaxanthin market. We believe that working alongside Stauber would accelerate the growth of our product across all categories,” says Boaz Ny, CEO of NextFerm Technologies.
“Astaferm is an outstanding product. It has a compelling story and a technology that places it above and beyond generic astaxanthin offerings today. We already see great interest in what we are offering across many products and applications” says Monica Mitchell, Stauber’s vice president of strategic brands sales and marketing.
Women in Nutraceuticals to hold first annual WIN Awards at SupplySide West 2024
October 16th 2024According to the organization’s press release, the awards program is designed to “celebrate the remarkable contributions and achievements of those who champion gender equity, drive research innovations, excel in mentorship within the nutraceutical sector, and significantly contribute to WIN’s programs.”
Kyowa Hakko USA to share new research on its Cognizin citicoline ingredient at SupplySide West 2024
Published: October 15th 2024 | Updated: October 15th 2024According to the company, the new research demonstrates the ingredient’s neuroprotective qualities and potential to enhance cognitive function, and support healthy brain aging.